NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹2,236 Cr | ₹2,247 Cr | ₹1,795 Cr | ₹1,681 Cr | ₹1,448 Cr |
What is the latest Total Expenditure of NATCO PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹2,236 Cr |
| Mar2024 | ₹2,247 Cr |
| Mar2023 | ₹1,795 Cr |
| Mar2022 | ₹1,681 Cr |
| Mar2021 | ₹1,448 Cr |
How is Total Expenditure of NATCO PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,236 Cr | -0.52 | |
| Mar2024 | ₹2,247 Cr | 25.18 | |
| Mar2023 | ₹1,795 Cr | 6.79 | |
| Mar2022 | ₹1,681 Cr | 16.09 | |
| Mar2021 | ₹1,448 Cr | - | |
Compare Total Expenditure of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,410.0 Cr | 0.2% | 9.9% | -34.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 0.2% |
9.9% |
-34.7% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses